Therabiol, Inc. — Form D
Therabiol, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-12. The offering totals $200K, of which $150K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-10-12
- Form: D
- Accession: 0001560268-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $200K
- Amount sold: $150K
- Remaining: $50K
- Investors: 6
- Date of first sale: 2012-09-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-185493
Issuer
- Name: Therabiol, Inc.
- CIK: 0001560268
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 2135 14TH AVENUE, SAN FRANCISCO, CA, 94116
- Phone: 415-476-4678
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Robert N Pressley | Director | San Francisco, CA |
| Devi N Vyas | Director | San Francisco, CA |
| Girish N Vyas | Director | San Francisco, CA |
| Robert N Pressley | Executive Officer | San Francisco, CA |
| Devi N Vyas | Executive Officer | San Francisco, CA |
| Girish N Vyas | Executive Officer | San Francisco, CA |
More